BMSMEDICAL
Home
Contact Us

For all other regions, please visit Global Medical Information Resource Center

BMS Medical Search

Enter your Question*

Enter at least two keywords
By searching, I confirm that my query is unsolicited.

Prior to granting you ("User") a license to use the Hypertrophic Cardiomyopathy Symptom Questionnaire (HCMSQ), please confirm your agreement to the terms and conditions below. Failure to agree to these terms will prohibit you from receiving a license. Any reference in these Terms and Conditions to "Bristol Myers Squibb" refers, collectively, to Bristol-Myers Squibb Company and all of its current and future subsidiaries and other affiliates.


  1. The HCMSQ is licensed solely for use in non-commercially funded studies or for clinical practice use. Any use of the HCMSQ in commercially-funded studies requires additional review. For inquiries or requests regarding its use in commercially-funded studies, please contact HCMSQ@bms.com.

  2. While Bristol Myers Squibb uses reasonable efforts to include accurate and up-to-date information in the HCMSQ website, Bristol Myers Squibb makes no warranties or representations as to its accuracy. Bristol Myers Squibb assumes no liability or responsibility for any errors or omissions in the HCMSQ. Without limiting the foregoing, the HCMSQ is provided to you "AS IS" WITHOUT WARRANTY OF ANY KIND, EITHER EXPRESSED OR IMPLIED, INCLUDING, BUT NOT LIMITED TO, THE IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE OR NON-INFRINGEMENT.

  3. Your access to, use of and browsing of the HCMSQ website are at your risk. Neither Bristol Myers Squibb nor any other party involved in creating, producing or delivering the HCMSQ and/or this website is liable for any direct, incidental, consequential, indirect or punitive damages arising out of your access to, or use of, the HCMSQ and this website. Bristol Myers Squibb assumes no responsibility, and shall not be liable for, any damages to, or viruses that may infect, your computer equipment or other property on account of your access to, use of, or browsing in the HCMSQ website or your downloading of any materials, data, text or images from the HCMSQ website.

  4. The HCMSQ is a tool designed to assess and monitor symptoms associated with hypertrophic cardiomyopathy. It is not intended to replace any clinical measures, diagnostic procedures, or medical evaluations of HCM. The HCMSQ should be used as a complementary resource and not as a substitute for the professional judgment of healthcare providers in diagnosing or treating HCM.

  5. Modification: User shall not modify, abridge, condense, adapt, recast or transform the Hypertrophic Cardiomyopathy Symptom Questionnaire (HCMSQ) in any manner or form, including but not limited to any minor or significant change in wordings or organization of the HCMSQ without the prior written agreement of the copyright holder of the HCMSQ, MyoKardia, Inc., a Bristol Myers Squibb Company.

  6. Translation: User shall not translate the HCMSQ without the prior written agreement from MyoKardia, Inc.

  7. Reproduction: User shall not reproduce the HCMSQ except for use in clinical practice or the study. In no event shall User distribute copies of the HCMSQ by any means to third parties except those specifically involved in the conduct of this clinical trial/Study/Project/Practice Use.

  8. User Manual: User shall follow the HCMSQ user manual and document any deviations thereto and include such deviations in publications if there is a plan to publish the data.

  9. Publication: A copy of all published papers and abstracts using the HCMSQ shall be provided to Bristol Myers Squibb in order to document the use of this instrument. All publications or presentations created by User shall cite:

    Reaney M, Allen V, Sehnert AJ, Fang L, Hagège AA, Naidu SS, Olivotto I. Development of the Hypertrophic Cardiomyopathy Symptom Questionnaire (HCMSQ): A New Patient-Reported Outcome (PRO) Instrument. Pharmacoecon Open. 2022 Jul;6(4):563-574. doi: 10.1007/s41669-022-00335-5. Epub 2022 Jun 2. PMID: 35653062; PMCID: PMC9283619.

    User shall not include a copy of the HCMSQ (original and/or any of its translations) in any publication.

  10. Copyright: It is understood that MyoKardia, Inc., the copyright holder of the HCMSQ, owns the copyright of both the HCMSQ and all its existing and future translations and/or derivations. To avoid any confusion as to ownership, a copyright notice shall be included on the original Questionnaire and all its translations as follows: © 2020 MyoKardia, Inc. MyoKardia, a Bristol Myers Squibb company, maintains version control of the scale and all future iterations.

  11. Fees: The HCMSQ is made available at no charge to User

  12. Termination: This license will remain in full force and effect until the duration of use is completed. User's rights will terminate automatically without notice if User fails to comply with any term(s) of this license agreement. Upon termination of this license agreement, User will cease all use of the HCMSQ. Except for this license granted (which shall terminate) and except as expressly provided otherwise herein, the terms of this license agreement will survive termination.

  13. Subject to the terms above, you agree to BMS' Terms of Use found at https://www.bms.com/legal-notice.html
Decline
Accept